Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$614.16 USD

614.16
1,397,594

-4.30 (-0.70%)

Updated Sep 12, 2024 04:00 PM ET

After-Market: $614.16 0.00 (0.00%) 6:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Trina Mukherjee headshot

3 MedTech Outperformers to Grab Amid Coronavirus Pandemic

Let's grab these three stocks that have shown tremendous promise amid the coronavirus pandemic.

Is Thermo Fisher Scientific (TMO) Stock Outpacing Its Medical Peers This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Abbott Banks on EPD, Nutrition Growth to Beat Coronavirus Woes

Abbott (ABT) expects to register strong growth for the second half of 2020 within established pharmaceuticals (EPD).

HealthEquity (HQY) Q2 Earnings and Revenues Beat Estimates

HealthEquity (HQY) witnessed strong growth in Service, Custodial and Interchange segments in Q2.

PRA Health (PRAH) Inks Deal With Leukemia & Lymphoma Society

PRA Health (PRAH) partners with LLS to bring new treatments for children with relapsed acute leukemia.

Bruker Banks on Strategic Innovation Amid Coronavirus Crisis

At Bruker's (BRKR) Germany campus, the company currently offers a pilot COVID-19 at work testing program for its factory workforce.

Henry Schein (HSIC) Enters Into New Dental Deal With Zyris

Henry Schien (HSIC) is set to be the exclusive distributor of Zyris products like Isolite 3, Isovac 2, Isodry and the company's patented single-use Mouthpieces.

Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio

Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

Nevro (NVRO) continues to gain traction from Senza, its flagship platform, and R&D capabilities. However, stiff competition remains a woe.

Varian's Halcyon System to Bring Improved Care to Singapore

Varian (VAR) strengthens its partnership Proton Therapy Pte as it brings improved care to Singapore through Halcyon system.

NextGen Healthcare Introduces New Behavioral Health Suite

NextGen Healthcare's (NXGN) new behavioral health suite aims to provide whole person care with support services for healthcare providers and clinicians.

Abbott Begins BTK Clinical Trial to Evaluate DRS Therapy

Abbott (ABT) aims to provide a new treatment option for patients with CLI BTK, thus eliminating the need for any additional treatment.

Boston Scientific's Eluvia Gets CMS' Additional Reimbursement

Boston Scientific (BSX) gains CMS' NTAP designation for its Eluvia stent system, thus providing additional reimbursement to Medicare beneficiaries suffering from PAD.

Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates

Cooper Companies' (COO) fiscal third-quarter earnings reflect dismal segmental performance. However, it exceeded expectation as it witnessed faster-than-anticipated recovery.

Aurora Cannabis (ACB) to Post Q4 Earnings: What's in Store?

Aurora Cannabis' (ACB) fiscal fourth-quarter results likely to reflect solid prospects in the Canadian market.

Patterson Companies (PDCO) Q1 Earnings Top Estimates, Up Y/Y

Despite weak performance across Patterson Companies' (PDCO) Dental and Animal Health segments in the fiscal first quarter results, it benefited from aggressive cost savings measures.

Madeleine Johnson headshot

Bear of the Day: Illumina (ILMN)

The coronavirus pandemic has dampened this medical stock's earnings and outlook.

Medtronic (MDT) Plans Up to $475M of Annual Cost Savings

Medtronic (MDT) expects its new operating model to help it become more focused in terms of speeding up research and developments.

Is Thermo Fisher (TMO) a Great Growth Stock?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Thermo Fisher (TMO).

ResMed (RMD) Launches First CPAP Nasal Mask With Memory Foam

ResMed (RMD) adds another product to its line of easy-to-use, convenient and comfortable masks.

Zacks.com featured highlights include: SGC, TMO, KR, WERN and ATVI

Zacks.com featured highlights include: SGC, TMO, KR, WERN and ATVI

Phirbo's Product Mix Aids, Global Animal Health Business Ails

Phirbo (PAHC) catered industries face issues like lack of processing availability and sudden drop in demand.

Medtronic's Pediatric Diabetes Device Gets Regulatory Nod

MiniMed 770G is Medtronic's (MDT) MiniMed 670G System's upgraded version.

OMRI Clears NEOGEN's AquaPrime Peraside 15 as USDA Compliant

NEOGEN (NEOG) completes organic certified water treatment program with the latest certification.

Syneos Health-Idorsia Collaborate to Launch Daridorexant in US

Syneos Health (SYNH) inks deal with Idorsia to commercialize the treatment for insomnia in the United States.